Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION

Search Results for 

Sort by date 45 pages found matching Zetia

  • Zetia heart attack may result in lawsuit
    Zetia , an anti-hyperlipidemic drug, is prescribed to treat high cholesterol. Since its FDA approval in 2002, serious Zetia side effects have been reported, including Zetia liver and Zetia heart attack problems. These Zetia problems have led to a number of Zetia lawsuits . Zetia is also used in conjunction with statins to lower cholesterol, but it has...
  • Critics Question Liptruzet
    May-5-13 Washington, DC Even though Liptruzet has only just been introduced on the market, at least one critic is questioning why the drug received approval. Liptruzet is a combination of Lipitor and Zetia, but Steven Nissen, of the Cleveland Clinic, says that because Zetia has not been proven to prevent heart attacks and strokes, approving it in combination with a...
  • Ezetrol Heart Attack and Stroke Legal Help
    Merck and Shering-Plough have announced that, based on a study of 720 patients, Vytorin, which combines Zetia (Ezetimibe) and Zocor (Simvastatin), does not reduce the growth of fatty arterial plaque. Rather, patients who took Vytorin had more plaque growth than patients who took only Zocor. In Canada, the drug Zetia is known as Ezetrol and is developed, m...
  • Merck, Schering Settle Vytorin Zetia Class Action
    Merck and Schering Plough have entered into $41.5 million settlement of class action lawsuits related to claims against their shared cholesterol medication Vytorin and Zetia. The suit revolved around allegations that the results from the Enhance Trial raised questions about the efficacy of the Zetia and Vytorin. The settlement will resolve approxi...
  • Vytorin Liver Damage and Heart Attack Risk
    Vytorin , a drug prescribed to treat high cholesterol, is a combination of the cholesterol-lowering Zetia and the statin Zocor. Since its FDA approval in 2004, serious Vytorin side effects have been reported, including Vytorin liver problems and statin cardiomyopathy , which can lead to Vytorin heart attack. Furthermore, the ENHANCE study in 2008 showed...
  • More Controversy Surrounding Zetia
    Jan-13-08 New York, NY: When the makers of Zetia announced that they were changing the goals of a clinical trial of the drug, after the trial had already been started, the companies faced a great deal of criticism. According to an article in Forbes, the situation was actually more controversial than that. The reason is that, according to Forbes, when the comp...
  • New Vytorin Study Results on the Way
    Sep-27-14 Washington, DC Another study is set to be released regarding the effectiveness of Vytorin , a drug that combines ezetimibe (known by the brand name Zetia) and simvastatin (known by the brand name Zocor). Whether the study will confirm previous findings that question the effectiveness of combining Zetia and Zocor is not known. Some previous studies have...
  • Ezetrol: Zetia by Any Other Name...
    Feb-25-08 Toronto, ON Canadian visitors to LawyersAndSettlements may wonder about all the recent uproar around Zetia , Merck Pharmaceuticals' costly and quite possibly ineffective anti-cholesterol drug, and its offshoot Vytorin , the combination Zetia/simvastatin (Zocor) drug produced jointly by Merck/Schering-Plough. Vytorin, of course, was the subject of the rec...
  • Zetia can have Serious Side Effects
    Jan-5-08 Seattle, WA: Patients taking Zetia are now learning that the drug may come with some serious side effects. Those include liver damage, rhabdomyolysis and myopathy. What has surprised many consumers is that the makers of Zetia conducted a few studies and found that there are risks associated with taking Zetia, but did not publicize the results of those st...
  • Zetia: Patient Complains About Severe Muscle Pain
    Jan-7-08 Doraville, GA: Charles S. says he is annoyed by Zetia. The problem is that within days of taking the drug, he experienced extreme muscle pain—pain that required steroids for relief. Charles has no doubt that the cause of his muscle pain was Zetia. "I was requested to take Zetia for cholesterol control, of course," Charles says. "So I did start t...
  • ARBITER 6-HALTS Results Not Good for Zetia
    Nov-17-09 Houston, TX Results of the ARBITER 6-HALTS trial of Zetia (ezetimibe) and Niaspan (niacin) show that Niaspan is more effective than Zetia as a cholesterol treatment. This news has caused some doctors to question whether or not to use Zetia to treat patients with high cholesterol. The results were published along with two editorials in the New England...
  • $688M Settlements Reached in Vytorin and Zetia ENHANCE Securities Class Actions
    New York, NY: Settlements totalling $688 million have been reached in the securities class actions pending against Merck & Co. Inc. ("Merck"), Schering-Plough Corporation ("Schering"), Merck/Schering-Plough Pharmaceuticals, certain of the Companies' directors and officers, and the underwriters of a 2007 Schering stock offering. The settlements, rea...
  • Vytorin and Zetia Setback
    Nov-15-09 Washington, DC How well do Vytorin and Zetia work? According to a new study released today, possibly not at all. Doctors are now questioning whether these two blockbuster cholesterol drugs should even be prescribed. This new study found that ezetimibe, the active ingredient in both Vytorin and Zetia, is significantly less effective at reducin...
  • Zocor Side Effects
    The Zocor cholesterol drug, a member of the class of drugs known as statins, is prescribed to many people with high cholesterol when diet and exercise are inadequate. Since 2002, the FDA has issued warnings about Zocor liver damage and increased Zocor myopathy (muscle damage) associated with statins. A recent Zocor SEARCH study shows that higher doses o...
  • Zetia: So Many Questions, So Few Answers
    Dec-26-07 Kenilworth, NJ In the five years since cholesterol drug Zetia has been on the market, millions of Americans have embraced Zetia to help them control their cholesterol levels. And yet, the safety of Zetia, and specifically concerns surrounding the potential for liver damage has been suspected for some time. In fact, prior to Zetia gaining US Food a...
  • Statins Star Rises, But Zetia?
    Jan-11-08 Kenilworth, NJ: The outlook on cholesterol-fighting statins only gets better, while cholesterol drug Zetia continues to be cloaked in a shroud of secrecy. At issue is a study on Zetia's safety and effectiveness that was completed two years ago by Merck and Schering-Plough, but was never released. The so-called Enhance study, which should give the best in...
  • Zetia: Feds Order Early Release of Enhance Trial Data
    Jan-4-08 Whitehouse Station, NJ: A study into the effectiveness of cholesterol drug Zetia completed months ago may shed new light on the true effectiveness of the Shering-Plough and Merck product, and the potential for liver damage. However, the manufacturer has been dragging its heels, so much so that the investigations subcommittee of the House Energy and Comme...
  • Zetia/Vytorin: "I can't afford to take any more chances."
    Jan-30-08 Huntington Beach, CA: George Stavros fits the profile of someone who would be prescribed Merck/Schering-Plough's Zetia anti-cholesterol drug to help prevent a possible heart attack. The question is whether it did him more harm than good. Stavros (not his real name pending possible legal action) has a history of cardiovascular disease dating back to 19...
  • Zetia and Vytorin Continue to be Controversial
    Aug-28-17 Washington, DC: There is little doubt that the cholesterol-fighting drug Zetia (ezetimibe) has travelled a rocky road since it was first approved by the US Food and Drug Administration (FDA) in 2002. And while several years have passed since the controversial delay in releasing study results into potential Zetia side effects , issues involving Zetia and...
  • Ayuda Legal Para Victimas de Ataque Cardiaco (Infarto) o Derrame Cerebral por Ezetrol
    Merck y Shering-Plough han anunciado que, sobre la base de un estudio de 720 pacientes, Vytorin, que combina Zetia (Ezetimiba) y Zocor (simvastatina), no reduce el crecimiento de la placa arterial grasosa. Por lo contrario, los pacientes que tomaron Vytorin tenian más crecimiento de placa que los pacientes que tomaron este fármaco sólo. En Canadá, la dro...
Page: 1  2  3     Next»



Request Legal Help Now! - Free